š¬ Current Disease Focus:
Task Progress: 0%
š„ Active Problem Solvers
0
š Experts collaborating globally
ā” Current Task Assignment
š§¬ Genetic Analysis
š Matching experts to specific tasks
š Resource Allocation by Research Phase:
š Data Analysis
š§Ŗ Experimental Design
š¬ Clinical Trials
š Treatment Development
Compile acute (30-day) clinical outcomes data and 9-month angiographic and ...
Status
Completed
Location
St. Vincent's Hospital - Sydney
Start Date
2009-03
Trial ID
NCT00824434
Treatments Being Tested
NET originate in neuroendocrine cells throughout the body. The goal of this...
Status
Unknown
Location
Oncology Centre, King Faisal Specialist Hospital & Research Center
Start Date
2012-12
Trial ID
NCT03629847
Treatments Being Tested
Percutaneous recanalization of total coronary occlusions (TCO) was historic...
Status
Completed
Location
AZ Middelheim
Start Date
2012-02
Trial ID
NCT01516723
Treatments Being Tested
This research is being done to study the safety and feasibility of implanti...
Status
Recruiting
Location
Dana-Farber Cancer Institute
Start Date
2024-12-01
Trial ID
NCT05700461
Treatments Being Tested
This trial evaluated the efficacy of an everolimus-based quadruple low immu...
Status
Completed
Location
Novartis Investigative Site
Start Date
2012-02-01
Trial ID
NCT01404325
Treatments Being Tested
The purpose of the SPIRIT IV Clinical Trial is to continue to evaluate the ...
Status
Completed
Location
Scottsdale Healthcare
Start Date
2006-08
Trial ID
NCT00307047
The purpose of this study is to learn if changing from Tacrolimus to Everol...
Status
Completed
Location
University of Kansas Medical Center
Start Date
2018-02-01
Trial ID
NCT03413722
Treatments Being Tested
This study is divided into 5 arms: 1. Randomized Clinical Trial (RCT): Pro...
Status
Completed
Location
Baptist Medical Center Princeton
Start Date
2005-06
Trial ID
NCT00180479
The purpose of this study is to evaluate the efficacy of two different drug...
Status
Completed
Location
Bad Segeberger Kliniken
Start Date
2007-12
Trial ID
NCT00598637
Treatments Being Tested
XIENCE VĀ® India is a prospective, open-label, multi-center, observational, ...
Status
Completed
Location
CARE Hospital
Start Date
2008-06
Trial ID
NCT00631228
Treatments Being Tested